Another perk of weight-loss drugs? Fewer colon cancer deaths, a study found
Ozempic can cost anywhere from over $1,000 to a $25, depending on how you pay for it. Peter Dazeley/Getty Images Colon cancer patients taking GLP-1 drugs, like Ozempic, had better odds of survival in a new study. Weight loss and diabetes injections have well-known anti-inflammatory benefits. It could be that Ozempic starves tumors, turning off […]
After years of rising drug prices, more discounts are here — at least for Medicare
Price are falling sharply for Medicare beneficiaries prescribed Novo Nordisk’s GLP-1 drugs like Ozempic in 2027.
Goodbye Ozempic, hello turkey: Americans say bye-bye to GLP-1 drug for a Thanksgiving feast
Millions of Americans on GLP-1 weight loss drugs are navigating Thanksgiving differently this year. Some are delaying injections to enjoy the holiday feast with a restored appetite, while others are adjusting portion sizes and opting for lighter dishes. The celebration is shifting towards a more mindful experience, prioritizing conversation and connection over overeating.
Medicare Secures 71% Price Cut On Novo’s Anti-Obesity Drug As Part Of Broad Affordability Push
Medicare Secures 71% Price Cut On Novo’s Anti-Obesity Drug As Part Of Broad Affordability Push The Trump administration is laser-focused on “Operation Affordability,” aiming to drive down the cost of food and healthcare ahead of the midterm election cycle. On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced a savings of 44%, or $12 […]
On a GLP-1? How to survive holiday meals without derailing your progress
While being on a GLP-1 can help to accelerate weight loss and regulate blood sugar, it also has the potential to change how people interact socially. As the holidays approach, sitting down for meals with family and lots of indulgent food may be challenging for those taking obesity drugs, as they tend to decrease appetite, […]
After Shutdown, Federal Employees Face New Uncertainty: Affording Health Insurance
Larry Humphreys, a retired Federal Emergency Management Agency worker in Moultrie, Georgia, says he and his wife won’t be traveling much next year after their monthly health insurance premium payment increases more than 40%, to $938. Humphreys, 68, feels betrayed by the Federal Employees Health Benefits Program. “As federal employees we sacrificed good salaries in […]
GLP‐1 Receptor Agonists for the Prevention of New‐Onset Heart Failure: A Systematic Review and Meta‐Analysis of Placebo‐Controlled Randomized Clinical Trials
ABSTRACT Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RA) improve outcomes in heart failure (HF) with preserved ejection fraction. Whether GLP-1 RA prevent new-onset HF in Type 2 diabetes or obesity requires further investigation. Methods We performed an updated meta-analysis of randomized placebo-controlled trials (RCT) of treatment with GLP-1 RA in participants without HF. The hazard […]
Healthcare, Vol. 13, Pages 3061: Analysis of Prediabetes in Veterans: Assessing Diagnosis and Population Characteristics Across a Region of Veterans Affairs Health Care Systems
Healthcare, Vol. 13, Pages 3061: Analysis of Prediabetes in Veterans: Assessing Diagnosis and Population Characteristics Across a Region of Veterans Affairs Health Care Systems Healthcare doi: 10.3390/healthcare13233061 Authors: Beth D. Greck Amanda T. Pons-Junkins Robert S. Colling Paula Richley Geigle Background/Objectives: Currently, 873,000 patients within the VA Health Administration potentially have prediabetes, based on HbA1c. […]
Study shows that 82% saw weight rebound and cardiovascular health reverse after withdrawal from taking GLP-1 drugs | Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity
submitted by /u/Hrmbee [link] [comments]
India’s pharmaceutical sector transition from generic to innovative drugs manufacturers, says CDSCO
NEW DELHI: India’s pharmaceutical sector is currently transitioning from a focus on generic drugs to the development of next-generation innovative biologics, as highlighted by the Central Drugs Standard Control Organization (CDSCO) of the Ministry of Health and Family Welfare, Government of India. This transition is driven by an innovation-focused ecosystem that emphasizes biosimilars, peptides, complex […]